Roger Sidhu - 20 Sep 2022 Form 4 Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Role: Chief Medical Officer
Signature: /s/ Roger Sidhu
Issuer symbol: ERNA
Transactions as of: 20 Sep 2022
Net transactions value: $0
Form type: 4
Filing time: 21 Sep 2022, 19:00:47 UTC
Previous filing: 17 Mar 2022
Next filing: 08 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ERNA	Common Stock	Options Exercise		+20,163			20,163	20 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ERNA	Restricted Stock Units	Options Exercise	$0	-20,163	-25%	$0.000000	60,487	20 Sep 2022	Common Stock	20,163		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit converts into one share of common stock.
F2	On September, 2021, the reporting person was granted 80,650 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date.